NOTICE -- Labnodes will be unavailable On Saturday evening to Sunday morning for scheduled maintenance. We appreciate your patience and we ask that you let us know if you experience any issues.
NOTICE: Labnodes now supports email addresses. If your email changed, please update your profile today.


Record History
Added on September 22, 2017 at 1:19 PM by Kimber, Jessica
Modified on September 25, 2017 at 10:21 AM by Kimber, Jessica
Shared with (contributions)
DRTC: Clinical Trials Master

Type 2 Diabetes Insulin Study

The purpose of this study is to evaluate the efficacy of U-500 insulin in patients with Type 2 Diabetes.


To qualify to participate:

  • 18 to 85 years of age

  • Diagnosed with Type 2 Diabetes

  • Body mass index ≥25 but ≤50 kilograms per meter squared

  • Have a history of stable body weight

  • Concomitant antihyperglycemic agent (AHA) therapy may include metformin (MET), dipeptidyl peptidase-4 inhibitors and/or pioglitazone


How to Participate

To participate, contact Dianne Davis at (615) 936-1140 or e-mail at